CHMP recommends five new drugs, reconsiders Eli Lilly’s Kisunla 

The European Medicines Agency’s human medicines committee (CHMP) recommended the authorization of five new medicines this week and announced that it has begun its reexamination of Eli Lilly’s Alzheimer’s drug Kisunla. CHMP

Jun 20, 2025 - 19:30
 0
CHMP recommends five new drugs, reconsiders Eli Lilly’s Kisunla 
The European Medicines Agency’s human medicines committee (CHMP) recommended the authorization of five new medicines this week and announced that it has begun its reexamination of Eli Lilly’s Alzheimer’s drug Kisunla. CHMP